INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹-99 Cr | ₹-78 Cr | ₹97 Cr | ₹142 Cr | ₹155 Cr |
What is the latest Profit After Tax of INDOCO REMEDIES ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹-99 Cr |
| Mar2025 | ₹-78 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹155 Cr |
How is Profit After Tax of INDOCO REMEDIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹-99 Cr | Negative | |
| Mar2025 | ₹-78 Cr | Negative | |
| Mar2024 | ₹97 Cr | -31.81 | |
| Mar2023 | ₹142 Cr | -8.11 | |
| Mar2022 | ₹155 Cr | - | |
Compare Profit After Tax of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,301.5 Cr | -5.3% | 14.3% | -14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -5.3% |
14.3% |
-14.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses